Effectiveness of a fourth dose of mRNA-1273 against COVID-19 among older adults in the United States: Interim results from an observational cohort study

We evaluated relative vaccine effectiveness (rVE) of 4- vs. 3-dose mRNA-1273 against SARS-CoV-2 infection, and COVID-19 hospitalization and death in immunocompetent adults aged ≥50 years at Kaiser Permanente Southern California. We included 178,492 individuals who received a fourth dose of mRNA-1273...

Descripción completa

Detalles Bibliográficos
Autores principales: Ku, Jennifer H., Sy, Lina S., Qian, Lei, Ackerson, Bradley K., Luo, Yi, Tubert, Julia E., Lee, Gina S., Florea, Ana, Bruxvoort, Katia J., Xie, Fagen, Qiu, Sijia, Chavers, Scott, Talarico, Carla A., Tseng, Hung Fu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Ltd. 2023
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10239903/
https://www.ncbi.nlm.nih.gov/pubmed/37301708
http://dx.doi.org/10.1016/j.vaccine.2023.06.016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10239903/
https://www.ncbi.nlm.nih.gov/pubmed/37301708
http://dx.doi.org/10.1016/j.vaccine.2023.06.016

Ejemplares similares